about
Phytochemical and antioedematogenic studies of commercial copaiba oils available in BrazilAntidepressant-like effects of Trichilia catigua (Catuaba) extract: evidence for dopaminergic-mediated mechanismsPreventive and therapeutic euphol treatment attenuates experimental colitis in micePronociceptive response elicited by TRPA1 receptor activation in miceTRPA1 receptor modulation attenuates bladder overactivity induced by spinal cord injuryEffects of indomethacin-loaded nanocapsules in experimental models of inflammation in ratsSynthetic and Biological Studies of Sesquiterpene Polygodial: Activity of 9-Epipolygodial against Drug-Resistant Cancer CellsRole of the macrophage inflammatory protein-1alpha/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptideThe "in vivo" and "ex vivo" roles of cylcooxygenase-2, nuclear factor-kappaB and protein kinases pathways in the up-regulation of B1 receptor-mediated contraction of the rabbit aorta.The role of kinin B1 and B2 receptors in the scratching behaviour induced by proteinase-activated receptor-2 agonists in miceKinins in pain and inflammation.Neurokinin mediation of edema and inflammation.The role of kinin receptors in preventing neuroinflammation and its clinical severity during experimental autoimmune encephalomyelitis in miceOmega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.EPA- and DHA-derived resolvins' actions in inflammatory bowel disease.Kinin B1 receptors mediate depression-like behavior response in stressed mice treated with systemic E. coli lipopolysaccharide.Characterization of kinin receptors modulating neurogenic contractions of the mouse isolated vas deferensMechanisms of bradykinin-induced contraction of the guinea-pig gallbladder in vitro.Synergistic effects of celecoxib and bupropion in a model of chronic inflammation-related depression in mice.The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).Effect of a kinin B2 receptor antagonist on LPS- and cytokine-induced neutrophil migration in rats.Mechanisms underlying the relaxation response induced by bradykinin in the epithelium-intact guinea-pig trachea in vitro.Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors.Relevance of tumour necrosis factor-alpha for the inflammatory and nociceptive responses evoked by carrageenan in the mouse pawAnti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor kappa B (NF-kappaB).TRPV1 channel inhibition contributes to the antinociceptive effects of Croton macrostachyus extract in miceInteractions of calcium antagonists and the calcium channel agonist Bay K 8644 on neurotransmission of the mouse isolated vas deferensMedicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives.Contribution of natural products to the discovery of the transient receptor potential (TRP) channels family and their functions.Inflammatory muscle pain is dependent on the activation of kinin B₁ and B₂ receptors and intracellular kinase pathwaysBiological activity of plant extracts: novel analgesic drugs.Wittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary aminesEffects of kinin B(1) and B(2) receptor antagonists on overactive urinary bladder syndrome induced by spinal cord injury in rats.Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptorTemporal and Regional Expression of Glucose-Dependent Insulinotropic Peptide and Its Receptor in Spinal Cord Injured Rats.Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain.Evidence for the role of neurogenic inflammation components in trypsin-elicited scratching behaviour in mice.Non-clinical studies required for new drug development - Part I: early in silico and in vitro studies, new target discovery and validation, proof of principles and robustness of animal studies.Role of CXCR2 and TRPV1 in functional, inflammatory and behavioural changes in the rat model of cyclophosphamide-induced haemorrhagic cystitis.Transient Receptor Potential Ankyrin 1 Channel Expression on Peripheral Blood Leukocytes from Rheumatoid Arthritic Patients and Correlation with Pain and Disability.
P50
Q28215260-B3D91B05-FAD7-4137-AE44-0B791DAD2C17Q28259327-4DCB5915-FF48-45A6-AD0D-F053433FEC36Q28477758-B265263E-D7A3-4A04-8A00-19D2FFB750A2Q28507198-B066AA17-21D1-4915-91DF-99518A1DC067Q28564612-6B588995-6A0E-40A1-BD54-CF8B2AFE84F1Q28579814-3DFEC4E6-DB1B-4658-85A4-3EC554AE74E7Q28834689-CE23C2C3-649E-4D8C-8FD2-A3E94571446BQ30490518-624B50AF-2489-4DCB-BF69-8A0F9A9D34BAQ31874663-746A017F-03F7-47C2-A28A-0EC6C133D345Q33690760-B3027E41-5F9E-4D93-8E99-9BF01191B95DQ33947824-514BEAF8-53F4-40C1-A3D3-8BC6D7D6C964Q34069430-EB762D0F-543E-40C8-B03D-657D560FB4CAQ34087938-27D94E09-128A-4D6B-A286-2073A54E9AADQ34197156-9A1357AF-4F97-4A6D-81D1-D0D57BF92376Q34491786-958A94D0-F50A-4C98-8E35-C5A56FFBF119Q34499830-E95A1F6D-20FA-49ED-A0F3-DCC3714946D9Q34793016-7D285CCE-E3C8-419C-A832-C55BF47534D4Q34793303-80593BAE-1D72-4BB9-B99C-C08D2F3C8E1BQ35006487-5F361FAA-EE0C-48E1-A4D2-2AB7F8039843Q35025703-85D2C4E7-A3D1-43B0-8984-CF678EC70877Q35045282-DCE1214C-3976-4CB5-894A-F3A59D431E55Q35048988-BC2B6EA1-E7D4-4F46-86EC-BF5CB8A706A1Q35177694-715681F4-0578-426D-97C3-166E860293ACQ35546232-606A052A-9236-4728-BA0A-A091F4FAC1CDQ35634667-01185140-918A-4DA3-9471-FEB6A3FBCC47Q35754245-2B31A3E7-145A-4C94-B598-1CA3306D5BCFQ35756217-8A5B36EF-B6A2-4D18-A01C-81D7CF4F15A3Q35904986-A1AC78A2-F7E3-4D53-8351-B18D36853BC2Q36113482-1557CC9E-1468-418F-8129-FA0C154F0DA9Q36158990-A27969AC-E0C0-4347-B475-E9FBA9018111Q36179675-17A0ED4D-89C1-48C5-BAA9-0AADAF943FDAQ36198988-865A83AC-42DD-4AE6-841E-872AC21F7349Q36476754-C08A5F47-14ED-42F9-B91E-D458B9534364Q36485064-77894CB0-8D2C-4430-AB18-41C4C0064724Q36554957-2B4B0BC3-4CFA-4950-8611-851073AD0B74Q36631076-BBDFB287-813C-413E-953C-2AFE94A0DBCEQ36753567-EAB82BD1-772B-4FD0-95D6-E864BFBEF05BQ37384418-5A2C27E0-6E65-4727-94DE-89C9F0CBBB03Q37522878-DF2C1354-0FDD-4A74-9B54-94D6A13B61F4Q37634729-7394A60A-95EC-4AE0-A4D4-76A925477CDC
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Calixto JB
@ast
Calixto JB
@es
Calixto JB
@nl
Joao Batista Calixto
@en
type
label
Calixto JB
@ast
Calixto JB
@es
Calixto JB
@nl
Joao Batista Calixto
@en
altLabel
Calixto JB
@en
prefLabel
Calixto JB
@ast
Calixto JB
@es
Calixto JB
@nl
Joao Batista Calixto
@en
P106
P1153
7102727168
P21
P31
P496
0000-0003-4041-7153